Efficacy of anthracycline/taxane‐based neo‐adjuvant chemotherapy on triple‐negative breast cancer in BRCA1/BRCA2 mutation carriers
暂无分享,去创建一个
T. Petit | D. Stoppa-Lyonnet | J. Fricker | L. Faivre | E. Mouret‐Fourme | C. Lasset | C. Noguès | O. Caron | M. Velten | V. Mari | P. Gesta | L. Gladieff | A. Lortholary | Akila Hamimi | Lucie Bignon | A. Hamimi